Company intelligence / Profile preview

EG BioMed

Taipei, Taipei, Taiwaneg-bio.com ↗

Ownership: Private
Development stage: Commercial

Overview

EG BioMed has developed a patented blood test technology that enables early, accurate, and non-invasive detection of cancers such as breast cancer. The technology leverages novel DNA methylation biomarkers validated on plasma-free DNA from patients. The company has received innovation awards in Taiwan and is expanding into the U.S. market with a CLIA-certified lab to support clinical trials. Licensing agreements are underway with YD Biopharma for global commercialization of their breast cancer assay.

Therapeutic areas: OncologyHematology
Modalities: Molecular diagnostics (e.g., real-time PCR, DNA methylation biomarkers)Liquid biopsy/blood-based cancer detection assays
Industry: Molecular Diagnostics

Drug pipeline

3 assets

Aging DNA Methylation Blood Test

Commercial

Indications: Aging biomarkers

2 more assets in the full pipeline.

Request access →

Partnerships

YD Biopharma Limited—licensing agreement for advanced breast cancer detection technology covering the U.S., E.U., Asia-Pacific markets; also licensing pancreatic cancer early-detection tech from EG BioMed.Collaborations anticipated with U.S.-based medical institutions/research teams as part of expansion plans.

Beyond the preview

Go deeper on EG BioMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EG BioMed.

Explore the full profile